Ameriflex Group, Inc. Harrow Health, Inc. Transaction History
Ameriflex Group, Inc.
- $245 Billion
- Q1 2025
A detailed history of Ameriflex Group, Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Ameriflex Group, Inc. holds 200 shares of HROW stock, worth $5,622. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$5,622
Previous $6.14 Million
13.41%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$111 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$60.4 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$53.1 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$52.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$26.9 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $761M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...